Log in to save to my catalogue

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer tra...

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer tra...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0966cd665c042128955928916e54faa

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

About this item

Full title

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

Publisher

London: BioMed Central Ltd

Journal title

BMC pulmonary medicine, 2021-06, Vol.21 (1), p.1-190, Article 190

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background The echinoderm microtubule-associated protein-like-4 anaplastic lymphoma kinase (EML4-ALK) fusion gene was identified in a subset of non-small cell lung cancer (NSCLC) patients. They responded positively to ALK inhibitors. This study aimed to characterize the mechanisms triggered by EML4-ALK to induce NSCLC transformation. Methods HEK293...

Alternative Titles

Full title

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d0966cd665c042128955928916e54faa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0966cd665c042128955928916e54faa

Other Identifiers

ISSN

1471-2466

E-ISSN

1471-2466

DOI

10.1186/s12890-021-01553-z

How to access this item